Abbott’s Compounding Pharmacy Recalls Products
Abbott’s Compounding Pharmacy voluntarily recalls sterile products due to lack of sterility assurance.
On Jan. 16, 2016, Abbott’s Compounding Pharmacy announced it was voluntarily recalling all unexpired lots of human and animal sterile compounded products including injectable medications, sterile solutions, eye drops, and eye ointments. The recall is in response to a concern of a lack of sterility assurance after a series of onsite FDA inspections. The recalled products were distributed in California.
The recall is cautionary and the company has not received any reports of adverse events regarding the recalled products as of Jan. 16, 2016. However, because microbial contamination could cause serious effects, the company is advising customers to stop using the products immediately and contact their healthcare provider if they experience problems related to the use of the products.
Source: FDA
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
AES Clean Technology Launches Next-Generation OSM Utility Solution for Cleanrooms at INTERPHEX 2025
April 2nd 2025Officially launched at INTERPHEX 2025, the Omni ASCENT is a next-generation off-site manufactured vertical utility solution that offers optimized cleanroom flexibility and efficiency.
